Navigation Links
Amnis Receives Broad Patent Coverage for Diagnostic Cell Imaging
Date:4/20/2009

SEATTLE, April 20 /PRNewswire/ -- Amnis Corporation, a manufacturer of advanced cell imaging systems, announced today that it has received U.S. patent 7,522,758. The patent, entitled Blood and Cell Analysis Using an Imaging Flow Cytometer, broadly covers diagnostic uses of multispectral cell imaging in flow or on slides and expands the company's intellectual property estate to 32 issued U.S. patents plus multiple foreign counterparts.

"Amnis' ImageStream(R) platform was designed to achieve tremendous speed and high fluorescence sensitivity while providing rich diagnostic information in the form of multiple images per cell," remarked William Ortyn, Amnis' co-founder and Chief Operations Officer. "With its ability to image hundreds of thousands of cells in minutes, directly in flow, ImageStream combines the diagnostic strengths of high resolution microscopy and flow cytometry in a single platform," added Ortyn.

"Our technology is a natural fit for the minimally-invasive diagnostic analysis of cells in bodily fluids. ImageStream enables the identification and functional analysis of even extremely rare cells that are indicative of disease, such as circulating tumor cells," said David Basiji, Ph.D., Amnis' President and Chief Executive Officer. Basiji added, "We are actively collaborating with our clinical partners on the development of diagnostic applications and are pleased that we now have broad intellectual property in multiple diagnostic areas."

About Amnis: Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets instrumentation for high speed cell imaging for research and diagnostic markets.


'/>"/>
SOURCE Amnis Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Renal Dietitian, Linda McCann, Receives 2009 Champion of Hope Award
2. Pitt receives $2.8 million to train HIV/AIDS researchers in Mozambique, Brazil and India
3. Wellesse Receives Corporate Sponsor of the Year Award From the Arthritis Foundations Pacific Northwest Chapter
4. Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study
5. Zultys Inc. Receives 2009 NGN Leadership Award from NGN Magazine
6. Sage Intergy EHR Receives 08 CCHIT Certification
7. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
8. ExpressMD(TM) Solutions Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA
9. Alseres Pharmaceuticals, Inc. Receives Notice of De-Listing of Its Securities for Failure to Regain Compliance with Continued Listing Requirements
10. Milton resident receives the Helen B. Spaulding Community Conscience Award
11. IDM Pharma Receives Nasdaq Shareholder Equity Notification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 , ... Vida ... an $18M Series B led by Canvas Ventures . Other investors include Nokia ... scale its mobile platform to serve more consumers who are managing chronic conditions ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...
(Date:12/8/2016)... Louis, MS (PRWEB) , ... December 08, 2016 , ... ... that serve commercial and residential clients in and around the Hancock County area, is ... for the Hancock County Food Pantry. , The Hancock County Food Pantry has worked ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... ... with the announcement that it is one of the early adopters completing EU-U.S. Privacy ... Framework is designed to provide companies on both sides of the Atlantic with a ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Kenall Manufacturing, ... new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that ... amount of light where and when it’s needed. , A 2’ x ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... SOUTH SAN FRANCISCO, Calif. , Dec. 8, ... engineered nuclease technology to develop novel antiviral therapeutics, ... , M.D., as chief executive officer and a ... "Dirk is an incredibly experienced executive with a ... companies," said Stephen Quake, D.Phil., founder of Agenovir, ...
(Date:12/8/2016)... N.J., Dec. 8, 2016 CANTEL MEDICAL CORP. (NYSE: ... of $18,800,000, or $0.45 per diluted share, on a 22.1% ... quarter ended October 31, 2016. This compares with net income ... $153,779,000 for the first quarter ended October 31, 2015. ... quarter ended October 31, 2016 to $21,323,000, or $0.51 per ...
(Date:12/8/2016)... 8, 2016 Stock-Callers.com revisits the ... distribution, and marketing of pharmaceutical drug products. Companies in ... and expiration. Additionally, these firms typically have dividend yields ... whole. Up for review this morning are: Novo Nordisk ... (NASDAQ: SGYP ), Pernix Therapeutics Holdings Inc. ...
Breaking Medicine Technology: